aldosterone has been researched along with Hyperlipoproteinemia Type II in 2 studies
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan (50 mg/day) was given to a patient with coronary heart disease who had been treated by DSC-LDL apheresis and had experienced an anaphylactoid reaction by administration of an angiotensin converting enzyme inhibitor." | 1.30 | Effects of losartan on low-density lipoprotein apheresis. ( Kojima, S; Kuramochi, M; Saotome, M; Shida, M; Tanaka, K; Yoshitomi, Y, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, S | 1 |
| Yoshitomi, Y | 1 |
| Saotome, M | 1 |
| Tanaka, K | 1 |
| Shida, M | 1 |
| Kuramochi, M | 1 |
| Khashimov, KhA | 1 |
| Vorontsov, VI | 1 |
| Kurdanov, KhA | 1 |
| Konovalov, GA | 1 |
| Atakhanov, ShE | 1 |
2 other studies available for aldosterone and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Effects of losartan on low-density lipoprotein apheresis.
Topics: Aldosterone; Antihypertensive Agents; Bradykinin; Combined Modality Therapy; Follow-Up Studies; Huma | 1999 |
[Effect of plasmapheresis on plasma hormone levels in patients with hereditary hypercholesterolemia].
Topics: Adult; Aldosterone; Angiotensin I; C-Peptide; Calcitonin; Estradiol; Female; Growth Hormone; Hormone | 1986 |